Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Fulkerson

Orthopaedic Trauma Walnut Creek, CA Medical Doctor

NPI 1568581429 CMS profile 71115

2625 Shadelands Dr, Walnut Creek, CA 94598

Open in the dashboard

General payments

$117,274

146 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eric Fulkerson of Walnut Creek, CA is reported in the CMS Open Payments database as having received $117,274 across 146 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,049 11
2024 General $4,973 16
2023 General $5,884 21
2022 General $1,542 18
2021 General $15,047 15
2020 General $75,920 22
2019 General $4,859 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Fulkerson
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Eric Fulkerson were reported at $9,049. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Eric Fulkerson Orthopaedic Trauma median Middle half National median
2019 $4,859 $1,475 $264–$6,401 $163
2020 $75,920 $596 $120–$4,020 $114
2021 $15,047 $919 $171–$4,697 $132
2022 $1,542 $1,547 $272–$7,240 $149
2023 $5,884 $1,330 $247–$5,875 $160
2024 $4,973 $1,288 $277–$6,797 $164
2025 $9,049 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $55,344 51 payments
  2. Conventus Orthopaedics, Inc. $54,833 3 payments
  3. Flower Orthopedics Coporation $1,913 1 payment
  4. SI-BONE, Inc. $1,420 19 payments
  5. Stryker Corporation $1,057 8 payments
  6. Zimmer Biomet Holdings, Inc. $763 9 payments
  7. Arthrex, Inc. $560 7 payments
  8. Bioventus LLC $339 13 payments
  9. Paragon 28, Inc. $149 5 payments
  10. Bard Access Systems, Inc. $137 2 payments
  11. Other $759 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $79,789 15 payments
  2. Royalty or License $16,505 10 payments
  3. Travel and Lodging $9,050 18 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,600 2 payments
  5. Food and Beverage $4,330 101 payments
Products named General payments · program years 2019–2025
  1. A/R Femoral Nail $12,473 6 payments
  2. Cerclage Cable Fixation $10,094 2 payments
  3. AUTOBAHN $8,943 6 payments
  4. EVO Retrograde $8,013 8 payments
  5. TROCH NAIL $7,600 2 payments
  6. Clavical Fixation (16-186) Spine $3,610 4 payments
  7. Clavical Fixation (16-186) Spine/Joint $1,743 2 payments
  8. ACTISHIELD $748 1 payment
  9. Clavical Fixation (16-186) Trauma $543 2 payments
  10. IFUSE IMPLANT SYSTEM $483 1 payment
  11. Other $5,491 104 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

65

Median for Orthopedic Surgery: 203

Drug cost

$226

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 53 $190
Ibuprofen Generic 12 $35

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 132 billing codes

Paid by Medicare

$197,447

Of which drugs: $4,235

Medicare patients

399

Average age 76

Services billed

1,299

282 women, 117 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Arthritis 58%
Depression 30%
Osteoporosis 30%
Diabetes 27%
Atrial fibrillation 26%
Chronic kidney disease 24%
Ischemic heart disease 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 21 162 $125

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record